These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1255255)

  • 1. Distribution and retention of 35S-sodium sulfate in man.
    Woodard HQ; Pentlow KS; Mayer K; Laughlin JS; Macrcove RC
    J Nucl Med; 1976 Apr; 17(4):285-9. PubMed ID: 1255255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer institute.
    Rutz HP; Weber DC; Goitein G; Ares C; Bolsi A; Lomax AJ; Pedroni E; Coray A; Hug EB; Timmermann B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):220-5. PubMed ID: 18068310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
    Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD
    J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1--Clinical outcomes.
    Foweraker KL; Burton KE; Maynard SE; Jena R; Jefferies SJ; Laing RJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):509-16. PubMed ID: 17524633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
    Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I regulation of Swarm rat chondrosarcoma chondrocytes in culture.
    Seong SC; Matsumura T; Lee FY; Whelan MC; Li XQ; Trippel SB
    Exp Cell Res; 1994 Apr; 211(2):238-44. PubMed ID: 8143769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The combination treatment of malignant bone tumors using fast neutrons].
    Chernichenko VA; Tolstopiatov BA; Konovalenko VF; Monich AIu; Palivets AIu
    Vopr Onkol; 1990; 36(8):970-3. PubMed ID: 2219842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demonstration of the uptake of 35S by chondrosarcomas (author's transl)].
    Nemec HW; Remagen W
    Nuklearmedizin; 1980; 19(5):250-4. PubMed ID: 7465438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.